TTRX
Turn·NASDAQ
--
--(--)
--
--(--)
0.80 / 10
Underperform
Turn Therapeutics exhibits weak fundamentals: key ratios such as Net profit margin (-2972.64%), Net profit / Revenue (-2164.14%), and EBIT / Revenue (-3056.43%) are deeply negative, signaling severe profitability issues. Valuation metrics like Asset-MV (-0.50) and Revenue-MV (-0.26) fall in unfavorable quartiles, and historical back-tests for these factors show negative monthly returns. Only Net profit attributable to parent shareholders / Net profit (100%) is positive but insufficient to offset other deficits, leading to an overall underperform rating.
Analysis Checks(1/10)
Revenue-MV
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Total operating revenue (YoY growth rate %)
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Net income-Revenue
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Current assets turnover ratio
Value1.78
Score1/3
Weight4.63%
1M Return-1.72%
Value1.78
Score1/3
Weight4.63%
1M Return-1.72%
Asset-MV
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Net cash flow from operating activities / Operating revenue (%)
Value-1513.77
Score0/3
Weight15.95%
1M Return-7.70%
Value-1513.77
Score0/3
Weight15.95%
1M Return-7.70%
Net profit margin (%)
Value-2972.64
Score0/3
Weight16.62%
1M Return-8.03%
Value-2972.64
Score0/3
Weight16.62%
1M Return-8.03%
EBIT / Total operating revenue (%)
Value-3056.43
Score0/3
Weight15.72%
1M Return-7.44%
Value-3056.43
Score0/3
Weight15.72%
1M Return-7.44%
Net profit / Total operating revenue (%)
Value-2164.14
Score0/3
Weight16.30%
1M Return-7.85%
Value-2164.14
Score0/3
Weight16.30%
1M Return-7.85%
Revenue-MV
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Total operating revenue (YoY growth rate %)
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Net cash flow from operating activities / Operating revenue (%)
Value-1513.77
Score0/3
Weight15.95%
1M Return-7.70%
Value-1513.77
Score0/3
Weight15.95%
1M Return-7.70%
Net income-Revenue
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Net profit margin (%)
Value-2972.64
Score0/3
Weight16.62%
1M Return-8.03%
Value-2972.64
Score0/3
Weight16.62%
1M Return-8.03%
Current assets turnover ratio
Value1.78
Score1/3
Weight4.63%
1M Return-1.72%
Value1.78
Score1/3
Weight4.63%
1M Return-1.72%
EBIT / Total operating revenue (%)
Value-3056.43
Score0/3
Weight15.72%
1M Return-7.44%
Value-3056.43
Score0/3
Weight15.72%
1M Return-7.44%
Asset-MV
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Net profit / Total operating revenue (%)
Value-2164.14
Score0/3
Weight16.30%
1M Return-7.85%
Value-2164.14
Score0/3
Weight16.30%
1M Return-7.85%
Is TTRX undervalued or overvalued?
- TTRX scores 0.80/10 on fundamentals and holds a Premium valuation at present. Backed by its -2126.94% ROE, 0.00% net margin, -28.42 P/E ratio, 214.06 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.
